Effect of chlormadinone-containing contraceptives on carbohydrate and lipid metabolism in women with metabolic syndrome

Abstract

Today, the overweight problem is one of the most critical health problems worldwide. The World Health Organization views obesity as an epidemic affecting millions of people. Historically, in studies of the efficacy and safety of various contraception methods, obese patients were excluded from the sample due to a theoretically higher risk of developing complications. However, the degree of increased risk has not been definitively established. Also, it is known that obesity can cause the development of anovulation and oligomenorrhea. Still, according to recent studies, it has been shown that the majority of obese patients have regular ovulation and need to use contraceptives. In this regard, the feasibility and safety of using certain methods of contraception in a patient with obesity should be decided individually, taking into account all the components of a woman's somatic status and her desire to have children in the future.